B3-066 CBCL Thrombocytopenia Flashcards
small non-nucleated blood cells derived from bone marrow megakaryocytes
platelets
alpha granules
platelet factor V
fibrinogen
VWF
PDGF
dense granules
ADP
serotonin
calcium
normal peripheral blood smear
normal bone marrow
Gplb deficiency
Bernard-Soulier
GpIIb-IIIa deficiency
Glanzmann
platelet function tests
PFA-100
platelet aggregation test
bleeding test
test of platelet function that measures both platelet adhesion and aggregation
PFA test
Normal CT Collagen-ADP
elevated CT Collagen EPI
aspirin/NSAIDs
Normal or elevated CT Collagen-ADP
normal or elevated CT Collagen EPI
clopidogrel
elevated CT Collagen-ADP
elevated CT Collagen EPI
3
VWD
Bernard Soulier
Glanzmann
measures the ability of various agonists to platelets to induced in vitro activation and platelet-platelet activation
LTA
LTA: when agnoist is added
platelets aggregate and absorb less light
LTA: aggregation present only with ristocetin
glanzmann
LTA: aggregation is absent with high concentrations of ristocetin
Bernard Soulier
causes of thrombocytopenia
decreased platelet production
decreased platelet survival
sequestration in spleen
dilution
thrombocytopenia
aplastic anemia
metastatic carcinoma
ITP
foamy histiocytes in spleen
TTP
shistocytes
symptoms of thrombocytopenia
petechiae
ecchymoses
gum/nose bleeding
GI bleeding, hematuria, excessive menstrual flow
inherited platelet disorders
bernard-soulier
glanzmann
disorders of platelet sectretion
defective adhesion
bernard-soulier
defective platelet aggregation
glanzmann
acquired defects of thrombocytopenia
aspirin
uremia
typically occuring in females
TTP
typically occuring in children
HUS
inhibition/deficiency of ADAMTS13 causes decreased degradation of vWF multimers
TTP
triad of thrombocytopenia, MAHA, and acute kidney injury
TTP and HUS
triad+ fever+ neurologic symptoms
TTP
triad+ blood diarrhea
HUS
normal PTT and PT
disease processes
HUS/TTP
distinguishes from DIC
treatment TTP
plamaphoresis
glucocorticoids
rituximab
treatment HUS
supportive
in patients with renal failure, uremic toxins accumulate and interfere with platelet adhesion
uremic platelet dysfunction
destruction of platelets in spleen
anti GpIIb/IIIa antibodies cause splenic macrophages to injest platelets
ITP
may by idiopathic or secondary to autoimmune disorders
ITP
SLE, HIC, HCV, CLL
increased megakaryocytes on bone marrow biopsy, decreased platelet count
ITP
treatment ITP
glucocorticoids
IvIg
rituximab
blood smear shows no platelet clumping
glanzmann
prolonged PT and PTT
decreased platelets
decreased fibrinogen
elevated D dimer
DIC
thrombocytopenia and anti-platelet antibodies
ITP
what clinical feature is most likely to be seen in ITP?
petechiae
classic pentad of TTP
fever
thrombocytopenia
MAHA
neurologic abnormalities
renal failure
TTP is caused by autoantibodies that inhibit
ADAMTS13
vWF cleaving protease
ADAMTS13